PHASE-I CLINICAL-STUDIES OF 7432-S, A NEW ORAL CEPHALOSPORIN - SAFETY AND PHARMACOKINETICS

被引：41

作者：

NAKASHIMA, M ^{[1
]}

UEMATSU, T ^{[1
]}

TAKIGUCHI, Y ^{[1
]}

MIZUNO, A ^{[1
]}

IIDA, M ^{[1
]}

YOSHIDA, T ^{[1
]}

YAMAMOTO, S ^{[1
]}

KITAGAWA, K ^{[1
]}

OGUMA, T ^{[1
]}

ISHII, H ^{[1
]}

YAMADA, H ^{[1
]}

机构：

[1] SHIONOGI & CO LTD,SHIONOGI RES LABS,OSAKA 553,JAPAN

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 28卷 / 03期

关键词：

D O I：

10.1002/j.1552-4604.1988.tb03140.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：246 / 252

页数：7

共 12 条

[1] HYPOPROTHROMBINEMIA CAUSED BY CEPHALOSPORINS [J].

ANDRASSY, K ;

BECHTOLD, H ;

RITZ, E .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (02) :133-136

[2] ANTIBIOTICS-INDUCED DISORDERS OF HEMOSTASIS AND COAGULATION [J].

DUDA, D ;

HEYES, H ;

WENSKE, C .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 109 (10) :388-392

[3] SYNTHESIS AND BIOLOGICAL PROPERTIES OF 7-BETA-[(Z)-2-(2-AMINO-4-THIAZOLYL)-4-CARBOXY-2-BUTENOYLAMINO]-3-CEPHEM-4-CARBOXYLIC ACID (7432-S), A NEW ORAL CEPHEM ANTIBIOTIC [J].

HAMASHIMA, Y ;

KUBOTA, T ;

MINAMI, K ;

ISHIKURA, K ;

KONOIKE, T ;

YOSHIOKA, M ;

YOSHIDA, T ;

NAKASHIMIZU, H ;

MOTOKAWA, K .

JOURNAL OF ANTIBIOTICS, 1987, 40 (10) :1468-1470

[4]

HIRANO K, 1986, 26TH INT C ANT AG CH

[5] PHARMACOLOGICAL EVALUATION OF CEFACLOR IN VOLUNTEERS [J].

HODGES, GR ;

LIU, C ;

HINTHORN, DR ;

HARMS, JL ;

DWORZACK, DL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) :454-456

[6]

METZLER CM, 1974, BIOMETRICS, V30, P562

[7]

NAKASHIMA M, 1988, J CLIN PHARMACOL, V28, P254

[8]

NEU HC, 1983, ANN INTERN MED, V98, P415

[9] ADVERSE REACTIONS AND INTERACTIONS WITH NEWER CEPHALOSPORIN AND CEPHAMYCIN ANTIBIOTICS [J].

NORRBY, SR .

MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1986, 1 (01) :32-46

[10]

Saito A, 1985, CHEMOTHERAPY S6, V33, P190

← 1 2 →